Table 1. Characteristics of study participants: NIPPON DATA2010.
All participants (N = 2,467) |
||
Age, years | 58.3 (15.7) | |
Sex, women, n | 1,438 (58.3%) | |
Regular exercise,a n | 831 (33.8%) | |
Smoking | Current smoker, n | 381 (15.5%) |
Ex-smoker, n | 460 (18.7%) | |
Alcohol consumption, g/week | 72.1 (133.7) | |
Body mass index, kg/m2 | 23.1 (3.4) | |
Systolic blood pressure, mm Hg | 132.1 (19.4) | |
Diastolic blood pressure, mm Hg | 79.4 (11.1) | |
HbA1c (NGSP), % | 5.8 (0.8) | |
Total cholesterol, mg/dL | 206.3 (35.1) | |
HDL cholesterol, mg/dL | 62.6 (16.0) | |
Hypertension,b n | 1,158 (46.9%) | |
Diabetes mellitus,c n | 254 (10.3%) | |
Hypercholesterolemia,d n | 1,030 (41.8%) | |
Low HDL cholesterol,e n | 181 (7.3%) |
HDL, high-density lipoprotein; NGSP, National Glycohemoglobin Standardization Program; NIPPON DATA2010, the National Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged 2010.
Data is shown as mean (standard deviation [SD]) or n (%).
aDefined as participants who engaged in exercise of ≥30 minutes for ≥2 days a week for more than one year.
bDefined as participants who meet one of the following criteria: (i) Systolic blood pressure/diastolic blood pressure of ≥140 mm Hg/≥90 mm Hg; (ii) Antihypertensive medication.
cDefined as participants who meet one of the following criteria: (i) Fasting plasma glucose level of ≥126 mg/dL; (ii) Non-fasting plasma glucose level of ≥200 mg/dL; (iii) Hemoglobin A1c ≥6.5%; (iv) Antidiabetic medication.
dDefined as participants who meet one of the following criteria: (i) Total cholesterol ≥220 mg/dL; (ii) Lipid-lowering medication.
eDefined as participants who meet the following criterion: (i) High-density lipoprotein cholesterol <40 mg/dL.